Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Assets (2016 - 2021)

Syndax Pharmaceuticals (SNDX) has 6 years of Return on Assets data on record, last reported at 0.08% in Q3 2021.

  • For Q3 2021, Return on Assets rose 27.0% year-over-year to 0.08%; the TTM value through Sep 2021 reached 0.08%, up 27.0%, while the annual FY2025 figure was 0.4%, 7.0% up from the prior year.
  • Return on Assets reached 0.08% in Q3 2021 per SNDX's latest filing, up from 0.15% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.08% in Q3 2021 and bottomed at 0.84% in Q4 2018.
  • Average Return on Assets over 5 years is 0.51%, with a median of 0.46% recorded in 2017.
  • Peak YoY movement for Return on Assets: tumbled -38bps in 2018, then surged 52bps in 2020.
  • A 5-year view of Return on Assets shows it stood at 0.46% in 2017, then tumbled by -82bps to 0.84% in 2018, then grew by 2bps to 0.82% in 2019, then skyrocketed by 64bps to 0.3% in 2020, then surged by 73bps to 0.08% in 2021.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.08% in Q3 2021, 0.15% in Q2 2021, and 0.19% in Q1 2021.